News archive
UT System Launches Clinical Trial Xpress to Help Accelerate the Drug Development Process
This week, the University of Texas (UT) System announced the launch of an innovative clinical trials network with the aim of getting the drugs and therapies developed by researchers at UT...
FDA Grants Breakthrough Therapy Designation For Hepatitis C Drugs Development Based on UT Health Science Center Research
The U.S. Food and Drug Administration (FDA) recently announced it has granted an amended Breakthrough Therapy Designation for an investigational combination of promising drugs to treat hepatitis C...
UT Southwestern Researcher Discusses New Strategies for Patient Recruitment in Clinical Trials
Last week during the 23rd Annual Research Appreciation Day (RAD), Dr. Robert Toto, Associate Dean for Clinical and Translational Research at UT Southwestern Medical Center in Dallas, appeared as a...
Too Many Prior Cancer Survivors Excluded from Lung Cancer Trials, According To UT Southwestern Study
Investigators Dr. Ethan Halm, Sandi Pruitt, Ph.D., Dr. Andrew Laccetti, Lei Xuan, Ph.D., and Dr. David Gerber A recent study led by a researcher from UT Southwestern revealed a fairly new...
MD Anderson Researchers, ASCO Weigh In On Whether Clinical Trials Really Work
Some 30,000 oncologists, medical researchers and marketers meet every year to present the latest advancements in cancer treatment at the annual meeting of the American Society of Clinical Oncology....
American Society of Clinical Oncology Recommends New Advancements For Clinical Trials
The American Society of Clinical Oncology (ASCO) has issued recommendations for a preliminary version for a new design for clinical trials during an annual session (June 2, 2013). Recent...
XBiotech Enrolls Its First Patient in Highly Anticipated Phase III Pivotal Trial of Xilonix
Texas based XBiotech enrolled the first patient in a Phase III trial of Xilonix by Dr. Eric Roeland at UC San Diego's Moores Cancer Center. The first True Human(TM) antibody, Xilonix exerts its...